Merck have published a series of selective and orally active neuropeptide Y Y5 receptor antagonists.
Filed under: gpcr | Tagged: antagonist, Merck, neuropeptide Y5, Y5 | Leave a Comment »
Merck have published a series of selective and orally active neuropeptide Y Y5 receptor antagonists.
Filed under: gpcr | Tagged: antagonist, Merck, neuropeptide Y5, Y5 | Leave a Comment »
Toray have publsihed a structure activity relationship paper on delta opioid receptor antagonist naltrindole derivatives as antitussives.
Filed under: gpcr | Tagged: antagonist, naltrindole, Opioid delta, Toray | Leave a Comment »
Targacept have initiated a Phase IIb trial of neuronal nicotinic receptor antagonist TC-5214 for the treatment of Major Depressive Disorder
Filed under: Uncategorized | Tagged: antagonist, neuronal nicotinic, Neuronal nicotinic receptor, phase II, Phase IIb, Targacept, TC-5214, TC5214 | Leave a Comment »